Trials / Recruiting
RecruitingNCT06091904
Effects of Sufentanil on the Intraoperative Hemodynamics
Effects of Sufentanil on the Intraoperative Hemodynamic Parameters in Patients Undergoing Extracranial-intracranial Bypass Surgery: a Prospective Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sufentanil | Induction: sufentanil TCI 0.3 ng/ml Maintenance: sufentanil TCI 0.05-0.5 ng/ml |
| DRUG | Remifentanil | Induction: remifentanil TCI 3 ng/ml Maintenance: remifentanil TCI 0.5-5 ng/ml |
Timeline
- Start date
- 2023-11-24
- Primary completion
- 2025-11-01
- Completion
- 2026-11-01
- First posted
- 2023-10-19
- Last updated
- 2025-09-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06091904. Inclusion in this directory is not an endorsement.